Veracyte, Inc. (VCYT) Earnings Call Analysis

NASDAQ · Healthcare · Diagnostics & Research

24/25

Growth 5 Margin 5 Expansion 5 Platform 4 Financial 5

latest quarter score

Earnings Reports

24
Veracyte (VCYT) Q2 2026: Prosigna Launch and 20% Decipher Growth Signal Expanding Oncology Franchise
July 31, 2026
22
Veracyte (VCYT) Q1 2026: Decipher Volumes Up 24% as Major Launches Set Stage for Next Growth Cycle
May 06, 2026
23
Veracyte (VCYT) Q4 2025: Decipher 21% Volume Growth Anchors 2026 Double-Digit Guidance
February 26, 2026
23
Veracyte (VCYT) Q3 2025: Decipher Volumes Up 26% as Margin Surges 650bps, Fueling Pipeline Acceleration
November 05, 2025
21
Veracyte (VCYT) Q2 2025: Decipher Volume Surges 28%, Anchoring Multi-Year Growth Trajectory
August 06, 2025
25
Veracyte (VCYT) Q1 2025: Decipher Volumes Jump 37% as Metastatic Launch Expands Prostate Franchise
July 04, 2025

Browse all companies